Clinical Connection Home
  Welcome To
Clinical Connection
 
Be notified of new studies!
Gout Clinical Trials, Diagnosis, and Treatment
Thank you for your interest in clinical trials for Gout.

Please click "Search" to find Gout clinical trials and medical research studies or read below for information on Gout diagnosis and treatment.

If you receive too many study listings you may enter your zip code to find the locations closest to you.


Any Of These Words:
OR
All Of These Words
OR
This Exact Phrase:
AND
Zip Code:
Distance:
Search results will appear below.
Your search returned 2 studies:


Gout - Tampa FL
Gout - DeLand FL
Browse All Available Clinical Trials

Join Now to be Notified of New Clinical Trials

View Information and Clinical Trials for Other Conditions


Gout

Gout (also called metabolic arthritis) is a disease due to a congenital disorder of the uric acid metabolism. In this condition monosodium urate crystals are deposited on the articular cartilage of joints and in particular tissues like tendons. This provokes an inflammatory reaction of these tissues. These deposits often increase in size and burst through the skin to form sinuses discharging a chalky white material.

Normally, the human bloodstream only carries small amounts of uric acid. However, if the blood has an elevated concentration of uric acid, uric acid crystals are deposited in the cartilage and tissue surrounding joints. Elevated blood levels of uric acid can also result in uric kidney stones.

Current Research

For current research articles click - here pain

Signs and Symptoms

The classic picture is of excruciating and sudden pain, swelling, redness, warmness and stiffness in the joint. Low-grade fever may also be present. The patient usually suffers from two sources of pain. The crystals inside the joint cause intense pain whenever the affected area is moved. The inflammation of the tissues around the joint also causes the skin to be swollen, tender and sore if it is even slightly touched. For example, a blanket draping over the affected area could cause extreme pain.

Gout usually attacks the big toe (approximately 75% of first attacks), however it can also affect other joints such as the ankle, heel, instep, knee, wrist, elbow, fingers, and spine. In some cases the condition may appear in the joints of the small toes which have become immobile due to impact injury earlier in life, causing poor blood circulation that leads to gout.

Patients with longstanding hyperuricemia (see below) can have uric acid crystal deposits called tophi (singular: tophus) in other tissues e.g. the helix of the ear. Uric acid stones can form as one kind of kidney stone in some occasions.

Diagnosis

The diagnosis is generally made on a clinical basis, although tests are required to confirm the disease.

Hyperuricemia is a common feature; however, urate levels are not always raised. Hyperuricemia is defined as a plasma urate (uric acid) level greater than 420 μmol/L (7.0 mg/dL) in males (or 380 μmol/L in females); however, high uric acid level does not necessarily mean a person will develop gout. Additionally, urate is within the normal range in up to two-thirds of cases. If gout is suspected, the serum urate test should be repeated once the attack has subsided. Other blood tests commonly performed are full blood count, electrolytes, renal function and erythrocyte sedimentation rate (ESR). This serves mainly to exclude other causes of arthritis, most notably septic arthritis.

A definitive diagnosis of gout is from light microscopy of joint fluid aspirated from the joint (this test may be difficult to perform) to demonstrate intracellular monosodium urate crystals in synovial fluid polymorphonuclear leukocytes. The urate crystal is identified by strong negative bi-refringence under polarised microscopy, and their needle-like morphology. A trained observer does better in distinguishing them from other crystals.

Pathogenesis

Gout arises directly from elevated levels of uric acid within the blood. The amount of uric acid within the body is determined by the balance between the amount being produced and the amount being excreted. Uric acid is produced when purines are broken down by enzymes in the liver. Purines can be generated by the body itself (via the breakdown of cells in normal cellular turnover) or can be ingested in purine-rich foods (e.g. seafood, beer). Most people with gout, however, do not produce more than the normal amount of uric acid. Instead, most people with gout tend to be underexcretors. The kidney is responsible for about one third of uric acid excretion, with the gut responsible for the rest. It may be possible that defects in the kidney that may be genetically determined are responsible for the predisposition of individuals for developing gout.

There are also different racial propensities to develop gout. The prevalence of gout is high among the peoples of the Pacific Islands, and the Māori of New Zealand, but rare in the Australian aborigine despite the latter's higher mean concentration of serum uric acid. In the United States, gout is twice as prevalent in African American males as it is in Caucasians.

Hyperuricemia is considered an aspect of metabolic syndrome, although its prominence has been reduced in recent classifications. This explains the increased prevalence of gout among obese individuals.

Many still believe that gout is caused by a combination of dietary factors and "laziness". In particular, many believe that gout develops following several years of excessive alcohol consumption combined with an ongoing lack of physical activity and a diet completely lacking in purine-neutralising foods, such as berries, as well as other specific fruit and vegetables (see below). Others have refined this theory, saying that some are genetically predisposed to gout and some are not. As a result, people who are not predisposed can live over-indulgent lifestyles and not develop gout, while others who are predisposed can develop gout, despite being physically active and having a well-rounded diet. However, most in the "genetic predisposition" school of thought nonetheless believe that the condition is much more likely to develop in the predisposed if the other factors are present over several years (excess alcohol, inactivity and failure to eat purine-neutralising foods). It is known that lead sugar was used to sweeten wine, and that chronic lead poisoning is a cause of gout, which condition is then known as saturnine gout, because of its association with alcohol and excess.

Gout can also develop as co-morbidity of other diseases, including polycythaemia, leukaemia, intake of cytotoxics, obesity, diabetes,hypertension, renal disorders, and hemolytic anemia. This form of gout is often called secondary gout. Diuretics (particularly thiazide diuretics) have traditionally been blamed for precipitating attacks of gout, but a Dutch case-control study from 2006 appears to cast doubt on this.

Stages of Gout

Gout has four distinct stages:
  1. Asymptomatic,
  2. Acute,
  3. Intercritical,
  4. Chronic.
In the first (asymptomatic) stage, plasma uric acid level increases, but there are no symptoms. The first attack of gout marks the second or acute stage. Mild attacks usually go away quickly, whereas severe attacks can last days or even weeks. After the initial attack, the person enters the intercritical stage or symptom-free interval that may last months or even years. Most gout patients have their second attack within 6 months to 2 years from their initial episode.

In the last or chronic stage, gout attacks become frequent and become polyarticular (affecting multiple joints at one time). Large tophi can also be found in many joints. In advanced cases of chronic gout, kidney damage, hypertension and kidney stones can also develop.

Treatment

Attacks

Acutely, first line treatment should be pain relief. Once the diagnosis has been confirmed, the drugs of choice are indomethacin, other nonsteroidal anti-inflammatory drugs (NSAIDs), or intra-articular glucocorticoids, administered via a joint injection.

Colchicine was previously the drug of choice in acute attacks of gout. It impairs the motility of granulocytes and can prevent the inflammatory phenomena that initiate an attack of gout. Colchicine should be taken within the first 12 hours of the attack and usually relieves the pain within 48 hours. Its main side-effects (gastrointestinal upset such as diarrhea and nausea) can complicate its use. The homeopathic preparation of the plant, Colchicum autumnale, from which Colchicine is derived, is a non-toxic alternative treatment. NSAIDs are the preferred form of analgesia for patients with gout.

Before medical help is available, some over the counter medication can provide temporary relief to the pain and swelling. NSAIDs such as ibuprofen can reduce the pain and inflammation slightly, although aspirin should not be used as it can worsen the condition. Preparation H hemorrhoidal ointment can be applied to the swollen skin to reduce the swelling temporarily. Professional medical care is needed for long term management of gout. Ice may be applied for 20–30 minutes several times a day. There are concerns that uric acid crystallization is accelerated by low temperature, but in a 2002 study in the Journal of Rheumatology patients who used ice packs had better relief of pain with no negative side effects. Keeping the affected area elevated above the level of the heart may help as well.

Due to swelling around affected joints for prolonged periods, shedding of skin may occur. This is particularly evident when small toes are affected and may promote fungal infection in the web region if dampness occurs; it is usually treated in a similar fashion to athlete's foot.

Prevention

Long term treatment (in frequent attacks) is antihyperuricemic therapy.

Because the body metabolizes purines into uric acid, a maintained, low-purine diet can help lower the plasma urate level. Avoiding alcohol, high-purine foods, such as meat, fish, dry beans (also lentils and peas), mushrooms, spinach, asparagus, and cauliflower can lower plasma urate levels. In addition, consuming purine-neutralizing foods, such as fresh fruits (especially cherries and strawberries) and most fresh vegetables, diluted celery juice, distilled water, and B-complex and C vitamins can also help lower plasma urate levels.

A possible "natural" cure is a berry extract supplement consisting of bilberry, blueberry or cherry extracts. The anthocyanins which give the berries their blue and purple hues, after entering the body, turn into powerful anti-inflammatories. These might be an especially preferable option to transplant patients, who frequently suffer gout due to increased toxicity and strain on the kidneys due to their immunosuppressant medication.

The mainstay of prevention is the drug allopurinol, a xanthine oxidase inhibitor, which directly reduces the production of uric acid. However, allopurinol treatment should not be initiated during an attack of gout, as it can then worsen the attack. If a patient is on allopurinol during an attack, it should be continued. However, if an attack occurs when the patient isn't on allopurinol yet, he has to wait until the end of the attack to start allopurinol.

The decision to use allopurinol is often a lifelong one. Patients have been known to relapse into acute arthritic gout when they stop taking their allopurinol, as the changing of their serum urate levels alone seems to cause crystal precipitation.

Allopurinol and uricosuric agents are contraindicated in patients with kidney stones and other renal conditions.

Additional measures

  • Febuxostat ((2-[3-cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid) - a novel non-purine inhibitor of xanthine oxidase seems to be an alternative that is superior to allopurinol; it is currently in Phase III trials.
  • Probenecid, a uricosuric drug that promotes the excretion of uric acid in urine, is also commonly prescribed - often in conjunction with colchicine. Interestingly, the drug fenofibrate (which is used in treating hyperlipidemia) also exerts a beneficial uricosuric effect.
  • As arterial hypertension quite often coexists with gout, treating it with losartan, an angiotensin II receptor antagonist, might have an additional beneficial effect on uric acid plasma levels. This way losartan can offset the negative side-effect of thiazides (a group of diuretics used for high blood pressure) on uric acid metabolism in patients with gout.
  • It is suspected that in many cases gout may be secondary to untreated sleep apnea, when oxygen-starved cells break down and release purines as a by-product. Treatment for apnea can be effective in lessening incidence of acute gout attacks.
  • A study in 2004 suggests that animal flesh sources of purine, such as beef and seafood, greatly increase the risk of developing gout. However, high-purine vegetable sources did not. Low fat dairy products such as skim milk significantly reduced the chances of gout. The study followed over 40 thousand men over a period of years, in which 1300 cases of gout were reported.
  • PEG-uricase, a polyethylene glycol ("PEG") conjugate of recombinant porcine uricase (urate oxidase), which breaks down the uric acid deposits is being studied in Phase III clinical trials for the treatment of severe, treatment-refractory gout in the United States in 2006.

Surgery

For extreme cases of gout, surgery may be necessary to remove large tophi and correct joint deformity.

Diet

It is well-established that a diet low in purines reduces the serum level of uric acid, the primary risk factor for gout. The solubility threshold for uric acid is approximately 6.7 mg/dl. Healthy subjects in the Normative Aging Study who had serum levels of uric acid over 9.0 mg/dl suffered a 22% incidence of gout over six years, compared to less than one percent for those with 7.0-8.9 mg/dl. The average uric acid level in men is 5.0 mg/dl, and substitution of a purine-free formula diet reduces this to 3.0 mg/dl. A purine-restricted diet lowers the level nearly as much (1-2 mg/dl). Ingestion of 500 mg of vitamin C per day has been shown to bring about a 0.5 mg/dl decrease in serum uric acid through increased excretion.

In a large prospective study, high consumption of meat and seafood were found associated with an elevated risk of gout onset (41% and 50%, respectively). High consumption of dairy products was associated with a 44% decrease in the incidence of gout. Consumption of purine-rich vegetables or a high protein diet had no significant correlation. Consumption of beer, which is rich in guanosine, is associated with a 49% increase in relative risk per daily 12-oz serving. By contrast, consumption of spirits was associated with only a 15% increase in relative risk, and no association at all was found with wine consumption.

Additional dietary recommendations can be made which target gout indirectly by opposing gout risk factors such as obesity, hypertension, cardiovascular disease, diabetes, and metabolic syndrome.

The following suggestions do not meet with universal approval among medical practitioners.

Low purine diet:
  • To lower uric acid:
    • cherries were reported to reduce uric acid in a small study
    • strawberries or blueberries (and other dark red/blue berries) are also reputed to be beneficial.
    • celery extracts (celery or celery seed either in capsule form or as a tea) is believed by many to reduce uric acid levels (although these are also diuretics). Celery extracts have been reported to act synergistically with anti-inflammatory drugs
    • any kinds of cheese. Cheese has been recommended as a low-purine food, and dairy products have been found to reduce the risk of gout.
  • Food to avoid:
    • foods high in purines
      • Limit food high in protein such as meat, fish, poultry, or tofu to 8 ounces (226 grams) a day. Avoid entirely during a flare up. Tofu has been proposed as a safe source of protein for gout patients due to its small and transient effect on plasma urate levels.
      • Tamarind
      • Sweetbreads, kidneys, liver, brains, or other offal meats
      • Sardines and anchovies
      • Seafood
      • Alcohol. Some claim that this applies especially to beer, on the basis that brewer's yeasts are very rich in purine. In view of the fact that most modern commercial beer contains trace amounts of yeast, this claim requires substantiation. Others claim that red wine is particularly bad for gout, though again it is difficult to find an explanation. Formerly, port wine was sweetened with litharge, causing lead poisoning, of which gout is a complication. Ironically, red wines, particularly those produced by traditional methods contain procyanidins released from grape seeds during wine making, which have been reported to lower serum uric acid levels by an indirect mechanism. However, withdrawal of urate-lowering therapy is associated with recurrence of acute gouty arthritis. Alcohol may also reduce the rate of uric acid excretion.
      • Meat extracts, consommés, and gravies
  • To avoid dehydration:
    • Drink plenty of liquids, especially water, to dilute and assist excretion of urates.
    • Avoid diet sodas (these act as diuretics in many people, causing uric acid to concentrate in the blood which can then easily precipitate).
    • Use sparingly diuretic foods or medicines like aspirin, vitamin C, tea and alcohol. The role of diuretics in triggering gout has been disputed.
  • Folklore has it that Joe-Pye weed flushes uric acid quickly, but continued use can damage the liver or kidneys
  • Another folk remedy is the use of oenomel, a drink with honey and unfermented grape juice.
  • Moderate intake of purine-rich vegetables is not associated with increased gout.


History

Gout was traditionally viewed as a disease of the decadent and indolent, because the foods which contribute to its development were only available in quantity to the wealthy. The stereotypical victim was a lazy, obese middle-aged man who habitually overindulged in rich foods and alcohol, with port wine consumption often cited as a specific cause. This stereotype is especially evident when gout is referred to as "The Disease of Kings".

Perhaps due to the traditional relationship between wealth and literacy, gout is one of the most commonly-reported maladies in history.

Writing ca. 30 AD, Aulus Cornelius Celsus appeared to recognize many of the features of gout, including its link with a urinary solute, late onset in women, linkage with alcohol, and perhaps even prevention by dairy products. "Again thick urine, the sediment from which is white, indicates that pain and disease are to be apprehended in the region of joints or viscera." and "Joint troubles in the hands and feet are very frequent and persistent, such as occur in cases of podagra and cheiragra. These seldom attack eunuchs or boys before coition with a woman, or women except those in whom the menses have become suppressed. Upon the commencement of pain blood should be let; for when this is carried out at once in the first stages it ensures health, often for a year, sometimes for always. Some also, when they have washed themselves out by drinking glasses' milk, evade this disease in perpetuity; some have obtained lifelong security by refraining from wine, mead and venery for a whole year; indeed this course should be adopted especially after the primary attack, even although it has subsided."

The Roman gladiatorial surgeon Galen described gout as a discharge of the four humors of the body in unbalanced amounts into the joints. The Latin term for a drop, as a drop of discharge, is gutta -- the term gout descends from this word.

Gout in Fiction

  • Benjamin Franklin, who was afflicted with gout, wrote a fictionalized account of a conversation he had with a "Madam Gout," where they listed together all the reasons why he was afflicted, in the literary piece Dialogue Between Franklin and The Gout
  • In Jules Verne's The Vanished Diamond (L’Étoile du sud, 1884), one of the main characters, John Watkins, is suffering from gout.
  • In Anton Chekhov's Uncle Vanya, the retired professor, Alexander Vladimirovitch Serebriakoff, suffers from gout.
  • In an episode of King of the Hill, Bobby Hill, age 13, eats nothing but chopped liver for awhile and develops gout. Hank Hill, Bobby's father, is shocked when he finds out, saying "That's an old man's disease!"
  • In an episode of Lost In Space, Will Robinson encounters Hamish Rhu-Glamis, a Scotsman executed in 1497, but who was suffering gout at the time of his death. Will's mother Maureen attempts to treat the gout when Hamish is made living again by passage through a space warp.
  • In George Eliot's Middlemarch, Tertius Lydgate publishes a book on gout.
  • In an episode of Everybody Hates Chris, Chris's father has gout in the episode "Everybody Hates The Gout."
  • In Archie Comics, the school principal Mr. Weatherbee was a long-time sufferer of gout.
  • In The Dukes of Hazzard, Boss Hogg regularly suffers from gout brought on by obesity, rich food and drink, and inactivity.
  • In the episode "Angel Gabriel Blue" of Keeping Up Appearances, Richard has a fungus infection on his feet, but Hyacinth prefers to tell everyone it's gout because it "afflicts those who over-indulge on finer living."
  • In the movie Captain Blood (1935), Dr. Peter Blood (Errol Flynn), a physician convicted of treason for treating a rebel against the crown (despite treating men of both sides) and thus sentenced to a life of slavery in Port Royal, Jamaica, tends to Governor Steed's (George Hassell) gouty foot.
  • Jiggs, husband of Maggie, in George McManus' long-defunct comic strip Bringing Up Father, ate large amounts of wonderfully rich food, especially corned beef and cabbage, bringing on very painful attacks of gout in the foot.
  • Matthew Bramble, an invalid gentleman in Tobias Smollett's c. 1750 novel Humphry Clinker, suffers from a number of ailments, including gout. He reluctantly takes the waters of Bath to attempt a cure.
  • In Jane Austen's last novel, Persuasion, Admiral Croft, arrives at Bath with orders "to walk to keep off the gout."
  • In the high fantasy series A Song of Ice and Fire, Prince Doran Martell suffers from a chronic case of gout.
  • In Charles Dickens's Bleak House, the stereotype of gout associated with the aristocracy is reinforced through the character Lord Dedlock and the male line of ancestors in the Dedlock family and is repeatedly referred to as the "family gout."
  • In the Adam Sandler song Lunch Lady Land are these lyrics: "I wear this hair net because my red hairs are falling out. / I wear these brown orthopedic shoes because I've got a bad case of gout!".
  • In the song "Great Big Stuff" from the Broadway musical "Dirty Rotten Scoundrels," gout is mentioned in the lyrics.
  • In the comic strip Katzenjammer Kids, the Captain often suffered from gout, always drawn in the form of a huge bandaged-up foot.
  • Gout is mentioned in the song "Impossible" from the musical A Funny Thing Happened on the Way to the Forum.
  • In Laurel and Hardy's Perfect Day (1929) the father is suffering from gout and has his left foot heavily wrapped up. This foot is hit at least 20 times by falling objects, closing doors, and so on throughout the episode.
  • In Calvin and Hobbes, when Calvin is forging a one-dollar bill, Hobbes remarks that "Ol' George has the gout, I see." This is a criticism of Calvin's forgery skills. (Strip dated November 3, 1987)
  • The character of the Lawyer, Mr. Bruff, in Wilkie Collins' book The Moonstone is described as suffering from an attack of gout.
  • High pitch Eric from the Howard Stern show is also afflicted with gout.
  • In the Flanders and Swann song 'Madeira M'Dear' the singer says that "Port is a wine I could well do without/ It's simply a case of 'chacun a son gout'". This French phrase means 'each to his own taste' but by pronouncing the last word in an Anglicised way it comes across as 'each to his own gout' - this is a pun drawing on the idea that drinking too much port was a cause of the condition.


(adapted from Wikipedia, the free encyclopedia http://en.wikipedia.org/wiki/Gout)





Findings From Current Research

Diagnosis of Gout by Ultrasound

Authors: Thiele RG, Schlesinger N.

Rheumatology Division, Department of Medicine Cooper University Hospital, Camden Rheumatology Division, Department of Medicine, UMDNJ/RWJMS, New Brunswick, NJ, USA

Objectives. To establish the usefulness of ultrasonography (US) for diagnosing gout and to determine whether there are sonographic features that are characteristic for gout but not for other arthropathies. Methods. We retrospectively compared joint images of gout patients with matching images from patients with other rheumatic conditions. Images of 37 joints of 23 patients with monosodium urate (MSU) crystal-proven gout were reviewed. MSU crystals were identified in at least one joint in each patient. Our control group had 23 randomly selected patients with 33 examined joints with rheumatic conditions other than gout. Results. Specific diagnostic features included a hyperechoic, irregular band over the superficial margin of the articular cartilage described as a double contour sign in 92% of gouty joints and in none of the controls (P < 0.001); hypoechoic to hyperechoic, inhomogeneous material surrounded by a small anechoic rim, representing tophaceous material, was seen in all gouty metatarsophalangeal (MTP) joints, in all metacarpophalangeal (MCP) joints and in none of the controls (P < 0.001); erosions adjacent to tophaceous material were seen in 65% of MTP joints and in 25% of MCP joints. One erosion was seen in a MTP joint in a control patient with psoriatic arthritis. Conclusions. US can detect deposition of MSU crystals on cartilaginous surfaces (P < 0.001) as well as tophaceous material and typical erosions. US may serve as a non-invasive means to diagnose gout.

Journal: Rheumatology (Oxford). 2007 Apr 27
Adapted from PubMed; click here to access full journal article.




Emerging Therapies in the Long-Term Management of Hyperuricaemia and Gout

Authors: Stamp LK, O'Donnell JL, Chapman PT

Department of Medicine, Christchurch School of Medicine and Health Sciences, University of Otago, Christchurch, New Zealand. lisa.stamp@cdhb.govt.nz

Gout is a common chronic arthritis that can lead to significant disability. Gout is one of the few rheumatological conditions that can be diagnosed with certainty, has a known cause and can be cured with appropriate therapy. Hypouricaemic agents reduce uric acid concentrations through inhibiting uric acid production (allopurinol) or enhancing uric acid excretion (probenecid, benzbromarone). Allopurinol is the most commonly used hypouricaemic agent but at recommended doses often fails to reduce adequately uric acid concentrations and prevent acute attacks of gout. The use of probenecid is limited by lack of efficacy in renal impairment. In the last few years, new agents in the management of hyperuricaemia and gout have become available. Febuxostat, a new xanthine oxidase inhibitor, is an effective hypouricaemic agent although further data are required for patients with renal impairment and other significant medical conditions. Rasburicase, a recombinant uricase (which catalyses the conversion of uric acid to the more readily excreted allantoin) is available for prevention of tumour lysis syndrome. However, its repeated use, as would be required in chronic gout, is limited by antigenicity. A less antigenic PEGylated uricase can rapidly reduce serum uric acid concentrations and promote resorption of tophi. However, further information with regard to the long-term risks and benefits of these agents is required. These agents may ultimately be used in the short term to rapidly deplete urate stores (induction therapy) followed by long-term therapy with an alternative hypouricaemic agent to prevent subsequent accumulation of uric acid (maintenance therapy).

Journal: Intern Med J. 2007 Apr;37(4):258-66
Adapted from PubMed; click here to access full journal article.




Metabolic Syndrome-Related Conditions Among People With and Without Gout: Prevalence and Resource Use

Authors: Novak S, Melkonian AK, Patel PA, Kleinman NL, Joseph-Ridge N, Brook RA.

Pharmacy Practice, University of Texas at Austin, Austin, TX, USA

OBJECTIVE: A cohort of employees with gout were compared to those without to evaluate the differences in prevalence of disorders associated with metabolic syndrome (both those considered underlying and those associated with end-stage morbidity and mortality) as well as the cost of annual medical services (AMS) required for treatment of these conditions. METHODS: Employees with gout were identified by International Classification of Diseases-9 (ICD-9) code during the calendar years of 2001-2004 and compared to propensity-score matched employees without gout using the Human Capital Management Services Research Reference Database. T-tests were then used to compare prevalence and average AMS of comorbid disorders defined from Agency for Healthcare and Research Quality (AHRQ) diagnostic categories. RESULTS: 'Hyperlipidemia', 'essential hypertension', and 'diabetes mellitus without complications' ranked in the top 10 categories of mean number of AMS for employees with gout using AHRQ specific categories; the values were higher than found for those without gout (all p < 0.0001). 'Essential hypertension', 'high cholesterol', 'diabetes mellitus without complications', and 'coronary atherosclerosis' showed an approximate 2:1 prevalence ratio for employees with gout over those without (p < or = 0.05). Main study limitations include the small number of subjects with gout, retrospective study design, and possible miscoding and/or non-coding of individuals with the studied disorders. CONCLUSION: These results support the continued need for patients with gout and their clinicians to be aware of the possibility of the increased risk of associated metabolic syndrome and related comorbidities in these individuals, emphasizing the need for prevention when possible and treatment when necessary.

Journal: Curr Med Res Opin. 2007 Mar;23(3):623-30.
Adapted from PubMed; click here to access full journal article.




Updates in The Management of Gout

Authors: Keith MP, Gilliland WR.

Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. mpkeith@bethesda.med.navy.mil

The majority of patients with gout are cared for by primary care physicians. Although both the physician and patient may easily recognize the acute arthritis of gout, errors in selecting the most appropriate medication and proper dose are common. The clinical stages of gout include asymptomatic hyperuricemia, intermittent gouty arthritis, and chronic tophaceous gout. Treatment of gout is usually considered after the first attack of arthritis, typically podagra. The aims of treatment are to alleviate the pain and inflammation associated with acute attacks, prevent future attacks, and decrease uric acid levels. Confusion frequently arises because certain medications such as colchicines may have dual purposes: to treat an acute attack and to suppress future attacks. The purpose of this management update is to provide practical advice about prescribing the proper medication considering both treatment goals and patient comorbidities.

Journal: Am J Med. 2007 Mar;120(3):221-4
Adapted from PubMed; click here to access full journal article.




Are Joints Affected by Gout Also Affected by Osteoarthritis?

Authors: Roddy E, Zhang W, Doherty M

Keele University, United Kingdom.

OBJECTIVES: To determine whether joints affected by gout are also affected by osteoarthritis (OA). METHODS: /B>A postal questionnaire was sent to all adults aged over 30 years registered with two general practices. The questionnaire assessed a history of gout (doctor diagnosed, or episodes suggestive of acute crystal synovitis) and medication use. Possible cases of gout attended for clinical assessment in order to verify the diagnosis on clinical grounds and assess the distribution of joints affected by acute attacks of gout and OA. Adjusted odds ratios (aOR) and 95% confidence intervals (CI) were calculated between the history of an acute attack of gout and the presence of OA at an individual joint adjusting for age, gender, BMI and prior diuretic use in a binary logistic regression model. RESULTS: /B>4249 completed questionnaires were returned (32%). From 359 attendees, 164 clinically confirmed cases of gout were identified. A highly significant association existed between the site of acute attacks of gout and the presence of OA (aOR 7.94; 95% CI 6.27, 10.05). Analysis at individual joint sites revealed a significant association at the 1st MTPJ (aOR 2.06; 95% CI 1.28, 3.30), mid-foot (aOR 2.85; 95% CI 1.34, 6.03), knee (aOR 3.07; 95% CI 1.05, 8.96) and distal interphalangeal joints (aOR 12.67; 95% CI 1.46, 109.91). CONCLUSION: /B>Acute attacks of gout at individual joint sites are associated with the presence of clinically assessed OA at that joint suggesting that OA may predispose to the localised deposition of MSU crystals.

Journal: Ann Rheum Dis. 2007 Feb 6
Adapted from PubMed; click here to access full journal article.




Therapeutic Advances in Gout

Authors: Pascual E, Sivera F

Rheumatology Section, Hospital General Universitario de Alicante, Alicante, Spain. pascual_eli@gva.es

PURPOSE OF REVIEW: The purpose of this review is to highlight the recent developments in the management of gout. RECENT FINDINGS: Guidelines for the diagnosis and management of gout from EULAR, quality of care indicators, and outcome measures for clinical trials have been published. The standards of gout diagnosis and management are very low. Allopurinol remains the mainstay for serum uric acid lowering therapy. In an important percentage of patients receiving allopurinol, serum uric acid levels are insufficient to promote crystal dissolution. Febuxostat, a new serum uric acid lowering drug, has shown good results. Information on uricase continues to appear. For treatment of gouty inflammation, etoricoxib (a new cyclooxygenase 2 inhibitor) has been shown to be as effective as indomethacin. Finally, the association of gout with the metabolic syndrome and its comorbidities, and the newly described association of gout with myocardial infarction, bring lifestyle and dietary modifications to the front in the management of gout. SUMMARY: Proper gout management requires changes to the physician's attitude towards the disease; essentially: (1) an unequivocal diagnosis based in urate crystal identification, (2) a clearly settled aim of the treatment: crystal elimination from the joints and elsewhere, and (3) proper use of the available therapeutic alternatives. Promoting a proper lifestyle appears to be especially important.

Journal: Curr Opin Rheumatol. 2007 Mar;19(2):122-7
Adapted from PubMed; click here to access full journal article.




Join Now - Become a free member and get notified about studies in your area when they become available.

Browse Our Current Studies - Look over all of our current studies being conducted throughout the United States.

View Information and Clinical Trials for Other Conditions - Access all of our health-related content.
Depression - Virginia Beach VA
in Virginia Beach, VA


Hypertension (High Blood Pressure) - Sacramento CA
in Carmichael, CA


Migraine - Virginia Beach VA
in Virginia Beach, VA


Bipolar Depression - Norristown PA
in Norristown, PA


Depression - Norristown PA
in Norristown, PA


Adolescent Depression - Virginia Beach VA
in Virginia Beach, VA


Major Depression - New York NY
in New York, NY


Bipolar Depression - New York NY
in New York, NY


Generalized Anxiety Disorder - New York NY
in New York, NY


Are You Ready to Quit Smoking? - Menlo Park CA
in Menlo Park, CA


Psoriasis - Baltimore MD
in Baltimore, MD


Migraine- Virginia Beach VA
in Virginia Beach, VA


ADHD in Children and Adolescents - Chapel Hill NC
in Chapel Hill, NC


Eczema (Atopic Dermatitis) - NATIONWIDE
in NATIONWIDE,


Osteoarthritis - Virginia Beach VA
in Virginia Beach, VA


Genital Warts - NATIONWIDE
in NATIONWIDE,


Diabetic Neuropathy - DeLand FL
in DeLand, FL


Osteoarthritis of the Knee - NATIONWIDE
in NATIONWIDE,


Healthy Volunteers (Sleep Disorders) - DeLand FL
in DeLand, FL


ADHD in Children and Adolescents - NATIONWIDE
in NATIONWIDE,


 


© 1998-2008 Clinical Trials Home | Links | Terms And Conditions | Sitemap | Suggestion/Feedback
All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted nationwide.
ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.